Suppr超能文献

诊断后体重变化对早期乳腺癌幸存者热潮状态的影响。

Effect of postdiagnosis weight change on hot flash status among early-stage breast cancer survivors.

机构信息

Kaiser Permanente, Northern California, Oakland, CA, USA.

出版信息

J Clin Oncol. 2012 May 1;30(13):1492-7. doi: 10.1200/JCO.2011.36.8597. Epub 2012 Mar 19.

Abstract

PURPOSE

Hot flashes (HF) affect a large proportion of breast cancer (BC) survivors and can negatively affect their quality of life. Treatments other than estrogen replacement to alleviate HF are needed. Body weight is related to hot flashes, but little is known about the effect of weight change on HF.

PATIENTS AND METHODS

We used data from 3,088 women previously treated for early-stage BC who were enrolled onto the Women's Healthy Eating and Living study to examine the association between weight change after a breast cancer diagnosis and the odds of reporting HF.

RESULTS

Overall, 36.1% of participants reported moderate to severe HF at study entry. At 2 years postdiagnosis, 69.2% of women remained within 10%, 4.8% lost at least 10%, and 26.0% gained at least 10% of their prediagnosis weight. Those who gained at least 10% of their prediagnosis weight had a greater risk of reporting HF than women who remained weight stable in that same period (odds ratio [OR], 1.33; 95% CI, 1.11 to 1.60; P = .003). Weight loss of at least 10% of prediagnosis weight was associated with a nonsignificant reduced risk (OR, 0.72; 95% CI, 0.47 to 1.08; P = .118) of reporting HF. However, the trend of weight change (weight loss and weight gain) on HF was significant both when examined categorically (P = .03) and continuously (P < .001).

CONCLUSION

Prevention of weight gain after a BC diagnosis-a modifiable behavior-may offer a viable intervention for relief of HF. Effects of intentional weight loss in BC survivors requires further study.

摘要

目的

热潮(HF)会影响很大比例的乳腺癌(BC)幸存者,并对其生活质量产生负面影响。需要寻找除雌激素替代疗法以外的治疗方法来缓解热潮。体重与热潮有关,但人们对体重变化对热潮的影响知之甚少。

患者和方法

我们使用了先前参加女性健康饮食与生活研究的 3088 名早期 BC 治疗后的女性的数据,以研究乳腺癌诊断后体重变化与报告热潮的几率之间的关系。

结果

总体而言,36.1%的参与者在研究开始时报告有中度至重度热潮。在诊断后 2 年时,69.2%的女性体重仍在 10%以内,4.8%的女性体重至少减轻了 10%,26.0%的女性体重至少增加了 10%。与体重稳定的女性相比,体重增加至少 10%的女性报告有热潮的风险更高(比值比[OR],1.33;95%置信区间[CI],1.11 至 1.60;P=.003)。体重减轻至少 10%的女性报告热潮的风险呈下降趋势,但无统计学意义(OR,0.72;95%CI,0.47 至 1.08;P=.118)。然而,当按类别(P=.03)和连续(P <.001)方式检查体重变化(体重减轻和体重增加)对热潮的影响时,这种趋势具有统计学意义。

结论

预防乳腺癌诊断后的体重增加——一种可改变的行为——可能为缓解热潮提供可行的干预措施。BC 幸存者的有意减重效果需要进一步研究。

相似文献

1
Effect of postdiagnosis weight change on hot flash status among early-stage breast cancer survivors.
J Clin Oncol. 2012 May 1;30(13):1492-7. doi: 10.1200/JCO.2011.36.8597. Epub 2012 Mar 19.
2
Weight gain is associated with increased risk of hot flashes in breast cancer survivors on aromatase inhibitors.
Breast Cancer Res Treat. 2010 Nov;124(1):205-11. doi: 10.1007/s10549-010-0802-6. Epub 2010 Feb 25.
3
Effects of stellate-ganglion block on hot flushes and night awakenings in survivors of breast cancer: a pilot study.
Lancet Oncol. 2008 Jun;9(6):523-32. doi: 10.1016/S1470-2045(08)70131-1. Epub 2008 May 15.
4
Randomized trial of a hypnosis intervention for treatment of hot flashes among breast cancer survivors.
J Clin Oncol. 2008 Nov 1;26(31):5022-6. doi: 10.1200/JCO.2008.16.6389. Epub 2008 Sep 22.
6
Stellate-ganglion block: a new treatment for hot flushes?
Lancet Oncol. 2008 Jun;9(6):506-7. doi: 10.1016/S1470-2045(08)70135-9.
7
Influence of hormone replacement therapy on tamoxifen-induced vasomotor symptoms.
J Clin Oncol. 2006 Aug 20;24(24):3991-6. doi: 10.1200/JCO.2005.04.3745.
8
Breast cancer survivors and hot flashes: the search for nonhormonal treatments.
J Clin Oncol. 2008 Nov 1;26(31):5008-10. doi: 10.1200/JCO.2008.18.2170. Epub 2008 Sep 22.
9
Using traditional acupuncture for breast cancer-related hot flashes and night sweats.
J Altern Complement Med. 2010 Oct;16(10):1047-57. doi: 10.1089/acm.2009.0472.
10
The addition of hormone therapy to tamoxifen does not prevent hot flashes in women at high risk for developing breast cancer.
Breast Cancer Res Treat. 2009 Aug;116(3):521-7. doi: 10.1007/s10549-008-0284-y. Epub 2009 Jan 13.

引用本文的文献

2
Impact of motivational interviewing on psychosocial and symptom outcomes during breast cancer endocrine therapy.
Support Care Cancer. 2025 Aug 23;33(9):805. doi: 10.1007/s00520-025-09760-8.
3
Management of vasomotor symptoms in cancer patients.
Oncologist. 2025 Feb 6;30(2). doi: 10.1093/oncolo/oyaf002.
4
Factors associated with weight gain in pre- and post-menopausal women receiving adjuvant endocrine therapy for breast cancer.
J Cancer Surviv. 2024 Oct;18(5):1683-1696. doi: 10.1007/s11764-023-01408-y. Epub 2023 Jun 1.
7
Nonhormonal Hot Flash Management for Breast Cancer Survivors: A Systematic Review and Network Meta-Analysis.
Evid Based Complement Alternat Med. 2020 Apr 28;2020:4243175. doi: 10.1155/2020/4243175. eCollection 2020.
8
Non-hormonal strategies for managing menopausal symptoms in cancer survivors: an update.
Ecancermedicalscience. 2019 Mar 11;13:909. doi: 10.3332/ecancer.2019.909. eCollection 2019.
9
Efficacy of a web-based women's health survivorship care plan for young breast cancer survivors: a randomized controlled trial.
Breast Cancer Res Treat. 2019 Aug;176(3):579-589. doi: 10.1007/s10549-019-05260-6. Epub 2019 May 3.
10
Survivorship, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology.
J Natl Compr Canc Netw. 2017 Sep;15(9):1140-1163. doi: 10.6004/jnccn.2017.0146.

本文引用的文献

1
An intensive behavioral weight loss intervention and hot flushes in women.
Arch Intern Med. 2010 Jul 12;170(13):1161-7. doi: 10.1001/archinternmed.2010.162.
2
Weight gain is associated with increased risk of hot flashes in breast cancer survivors on aromatase inhibitors.
Breast Cancer Res Treat. 2010 Nov;124(1):205-11. doi: 10.1007/s10549-010-0802-6. Epub 2010 Feb 25.
3
Physical activity, diet, adiposity and female breast cancer prognosis: a review of the epidemiologic literature.
Maturitas. 2010 May;66(1):5-15. doi: 10.1016/j.maturitas.2010.01.004. Epub 2010 Jan 25.
4
5
Hot flushes, coronary heart disease, and hormone therapy in postmenopausal women.
Menopause. 2009 Jul-Aug;16(4):639-43. doi: 10.1097/gme.0b013e31819c11e4.
6
Hot flashes and subclinical cardiovascular disease: findings from the Study of Women's Health Across the Nation Heart Study.
Circulation. 2008 Sep 16;118(12):1234-40. doi: 10.1161/CIRCULATIONAHA.108.776823. Epub 2008 Sep 2.
7
Pre-diagnosis body mass index, post-diagnosis weight change, and prognosis among women with early stage breast cancer.
Cancer Causes Control. 2008 Dec;19(10):1319-28. doi: 10.1007/s10552-008-9203-0. Epub 2008 Aug 28.
8
Risk factors for onset of menopausal symptoms: results from a large cohort study.
Maturitas. 2008 Jun 20;60(2):108-21. doi: 10.1016/j.maturitas.2008.04.004. Epub 2008 May 29.
9
Abdominal adiposity and hot flashes among midlife women.
Menopause. 2008 May-Jun;15(3):429-34. doi: 10.1097/gme.0b013e31815879cf.
10
Tamoxifen pharmacogenomics: the role of CYP2D6 as a predictor of drug response.
Clin Pharmacol Ther. 2008 Jan;83(1):160-6. doi: 10.1038/sj.clpt.6100367. Epub 2007 Sep 19.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验